Connect with us

Science

California needs biomass energy to meet its wildfire goals. Its projects keep going South

Published

on

California needs biomass energy to meet its wildfire goals. Its projects keep going South

Arbor Energy is, essentially, a poster child of the kind of biomass energy project California keeps saying it wants.

The state’s goal is to reduce wildfire risk on 1 million acres of wildlands every year, including by thinning overgrown forests, which is expected to generate roughly 10 million tons of wood waste annually. Arbor hopes to take that waste, blast it through a “vegetarian rocket engine” to produce energy, then sequester all of the carbon the process would generate underground.

California has billed Arbor — and the handful of other similarly aimed projects it’s financed — as a win-win-win: wildfire mitigation, clean energy and carbon sequestration all in one.

Yet, after Arbor initially won state financial backing for a pilot project in Placer County, the El Segundo-based company’s California ambitions fell through, like many biomass projects before it.

Instead, it’s heading to Louisiana.

Advertisement

California, biomass energy advocates say, has struggled to get past its distrust of the technology, given traditional biomass’ checkered past of clear-cutting forests and polluting poorer communities. Further, the state’s strict permitting requirements have given residents tremendous power to veto projects and created regulatory headaches.

But many environmental groups argue it’s an example of California’s environmental and health protections actually working. If not done carefully, bioenergy projects run the risk of emitting carbon — not sequestering it — and polluting communities already grappling with some of the state’s dirtiest air.

“When you look at biomass facilities across California — and we’ve done Public Records Act requests to look at emissions, violations and exceedances … the reality is that we’re not in some kind of idealized pen-and-paper drawing of what the equipment does,” said Shaye Wolf, climate science director at the Center for Biological Diversity. “In the real world, there are just too many problems with failures and faults in the equipment.”

There are simpler and safer uses for this wood waste, these critics say: fertilizer for agriculture, wood chips and mulch. It may not provide carbon-negative energy but comes with none of the risks of bioenergy projects, they say.

For the record:

Advertisement

11:51 a.m. Sept. 30, 2025A previous version of this story stated that the Center for Biological Diversity advocated for a wildfire approach involving only home hardening and evacuation planning. Its proposal also includes prescribed burning and defensible-space vegetation management.

The Center for Biological Diversity and others advocate for a more “hands-off” approach to California’s forests and urge management of the wildfire crisis primarily through home hardening, evacuation planning, prescribed burning and defensible-space vegetation management. But fire and ecology experts say more than a century of fire suppression has made that unrealistic.

However, the sweeping forest-thinning projects these experts say are needed will cost billions, and so the state needs every source of funding it can get. “Our bottleneck right now is, how do we pay for treating a million acres a year?” said Deputy Chief John McCarthy of the California Department of Forestry and Fire Protection, who oversees the agency’s wood products and bioenergy program.

In theory, the class of next-generation biomass energy proposals popping up across California could help fund this work.

“California has an incredible opportunity,” said Arbor chief executive and co-founder Brad Hartwig. With the state’s leftover biomass from forest thinning, “we could make it basically the leader in carbon removal in the world.”

Advertisement

A lot of wood with nowhere to go

Biomass energy first took off in California in the 1980s after small pioneering plants at sawmills and food-processing facilities proved successful and the state’s utilities began offering favorable contracts for energy sources they deemed “renewable” — a category that included biomass.

In the late ‘80s and early ‘90s, the state had more than 60 operating biomass plants, providing up to 9% of the state’s residential power. Researchers estimate the industry supported about 60,000 acres of forest treatment to reduce wildfire risk per year at the time. But biomass energy’s heyday was short-lived.

In 1994, the California Public Utilities Commission shifted the state’s emphasis away from creating a renewable and diverse energy mix and toward simply buying the cheapest possible power.

Biomass — an inherently more expensive endeavor — struggled. Many plants took buyouts to shut down early. Despite California’s repeated attempts to revitalize the industry, the number of biomass plants continued to dwindle.

Today, only 23 biomass plants remain in operation, according to the industry advocate group California Biomass Energy Alliance. The state Energy Commission expects the number to continue declining because of aging infrastructure and a poor bioenergy market. California’s forest and wildfire leadership are trying to change that.

Advertisement

In 2021, Gov. Gavin Newsom created a task force to address California’s growing wildfire crisis. After convening the state’s top wildfire and forest scientists, the task force quickly came to a daunting conclusion: The more than a century of fire suppression in California’s forests — especially in the Sierra Nevada — had dramatically increased their density, providing fires with ample fuel to explode into raging beasts.

To solve it, the state needed to rapidly remove that extra biomass on hundreds of thousands, if not millions, of acres of wildlands every year through a combination of prescribed burns, rehabilitation of burned areas and mechanically thinning the forest.

McCarthy estimated treating a single acre of land could cost $2,000 to $3,000. At a million acres a year, that’s $2 billion to $3 billion annually.

“Where is that going to come from?” McCarthy said. “Grants — maybe $200 million … 10% of the whole thing. So, we need markets. We need some sort of way to pay for this stuff and in a nontraditional way.”

McCarthy believes bioenergy is one of those ways — essentially, by selling the least valuable, borderline unusable vegetation from the forest floor. You can’t build a house with pine cones, needles and twigs, but you can power a bioenergy plant.

Advertisement

However, while biomass energy has surged in Southern states such as Georgia, projects in California have struggled to get off the ground.

In 2022, a bid by Chevron, Microsoft and the oil-drilling technology company Schlumberger to revive a traditional biomass plant near Fresno and affix carbon capture to it fell through after the U.S. Environmental Protection Agency requested the project withdraw its permit application. Environmental groups including the Center for Biological Diversity and residents in nearby Mendota opposed the project.

This year, a sweeping effort supported by rural Northern California counties to process more than 1 million tons of biomass a year into wood pellets and ship them to European bioenergy plants (with no carbon capture involved) in effect died after facing pushback from watch groups that feared the project, led by Golden State Natural Resources, would harm forests, and environmental justice groups that worried processing facilities at the Port of Stockton would worsen the air quality in one of the state’s most polluted communities.

Arbor believed its fate would be different.

Bioenergy from the ground up

Before founding Arbor, Hartwig served in the California Air National Guard for six years and on a Marin County search and rescue team. He now recalls a common refrain on the job: “There is no rescue in fire. It’s all search,” Hartwig said. “It’s looking for bodies — not even bodies, it’s teeth and bones.”

In 2022, he started Arbor, with the idea of taking a different approach to bioenergy than the biomass plants shuttering across California.

Advertisement

To understand Arbor’s innovation, start with coal plants, which burn fossil fuels to heat up water and produce steam that turns a turbine to generate electricity. Traditional biomass plants work essentially the same but replace coal with vegetation as the fuel. Typically, the smoke from the vegetation burning is simply released into the air.

Pipes and meters.

Small detail of the 16,000-pound proof-of-concept system being tested by Arbor that will burn biomass, capture carbon dioxide and generate electricity.

(Myung J. Chun/Los Angeles Times)

Arbor’s solution is more like a tree-powered rocket engine.

The company can utilize virtually any form of biomass, from wood to sticks to pine needles and brush. Arbor heats it to extreme temperatures and deprives it of enough oxygen to make the biomass fully combust. The organic waste separates into a flammable gas — made of carbon monoxide, carbon dioxide, methane and hydrogen — and a small amount of solid waste.

Advertisement

The machine then combusts the gas at extreme temperatures and pressures, which then accelerates a turbine at much higher rates than typical biomass plants. The resulting carbon dioxide exhaust is then sequestered underground.

Arbor portrays its solution as a flexible, carbon-negative and clean device: It can operate anywhere with a hookup for carbon sequestration. Multiple units can work together for extra power. All of the carbon in the trees and twigs the machine ingests ends up in the ground — not back in the air.

But biomass watchdogs warn previous attempts at technology like Arbor’s have fallen short.

This biomass process creates a dry, flaky ash mainly composed of minerals — essentially everything in the original biomass that wasn’t “bio” — that can include heavy metals that the dead plants sucked up from the air or soil. If agricultural or construction waste is used, it can include nasty chemicals from wood treatments and pesticides.

Arbor plans — at least initially — on using woody biomass directly from the forest, which typically contains less of these dangerous ash chemicals.

Advertisement

Turning wood waste into gas also generates a thick, black tar composed of volatile organic compounds — which are also common contaminants following wildfires. The company says its gasification process uses high enough temperatures to break down the troublesome tar, but researchers say tar is an inevitable byproduct of this process.

Two standing men look at a machine.

Grant Niccum, left, Arbor lead systems engineer and Kevin Saboda, systems engineer, at the company‘s test site in San Bernardino. Biomass is fed into this component and then compressed to 100 times atmospheric pressure and burned to create a synthetic gas.

(Myung J. Chun / Los Angeles Times)

Watchdogs also caution that the math to determine whether bioenergy projects sequester or release carbon is complicated and finicky.

“Biomass is tricky, and there’s a million exceptions to every rule that need to be accounted for,” said Zeke Hausfather, climate research lead with Frontier Climate, which vets carbon capture projects such as Arbor’s and connects them with companies interested in buying carbon credits. “There are examples where we have found a project that actually works on the carbon accounting math, but we didn’t want to do it because it was touching Canadian boreal forest that’s old-growth forest.”

Advertisement

Frontier Climate, along with the company Isometric, audits Arbor’s technology and operations. However, critics note that because both companies ultimately support the sale of carbon credits, their assessments may be biased.

At worst, biomass projects can decimate forests and release their stored carbon into the atmosphere. Arbor hopes, instead, to be a best-case scenario: improving — or at least maintaining — forest health and stuffing carbon underground.

When it all goes South

Arbor had initially planned to build a proof of concept in Placer County. To do it, Arbor won $2 million through McCarthy’s Cal Fire program and $500,000 through a state Department of Conservation program in 2023.

But as California fell into a deficit in 2023, state funding dried up.

So Arbor turned to private investors. In September 2024, Arbor reached an agreement with Microsoft in which the technology company would buy carbon credits backed by Arbor’s sequestration. In July of this year, the company announced a $41-million deal (well over 15 times the funding it ever received from California) with Frontier Climate, whose carbon credit buyers include Google, the online payment company Stripe and Meta, which owns Instagram and Facebook.

Advertisement

To fulfill the credits, it would build its first commercial facility near Lake Charles, La., in part powering nearby data centers.

“We were very excited about Arbor,” McCarthy said. “They pretty much walked away from their grant and said they’re not going to do this in California. … We were disappointed in that.”

But for Arbor, relying on the state was no longer feasible.

“We can’t rely on California for the money to develop the technology and deploy the initial systems,” said Hartwig, standing in Arbor’s plant-covered El Segundo office. “For a lot of reasons, it makes sense to go test the machine, improve the technology in the market elsewhere before we actually get to do deployments in California, which is a much more difficult permitting and regulatory environment.”

Two people crawl under machinery.

Rigger Arturo Hernandez, left, and systems engineer Kevin Saboda secure Arbor’s proof-of-concept system in the company’s San Bernardino test site after its journey from Arbor’s headquarters in El Segundo. The steel frame was welded in Texas while the valves, tubing and other hardware were installed in El Segundo.

(Myung J. Chun/Los Angeles Times)

Advertisement

It’s not the first next-generation biomass company based in California to build elsewhere. San Francisco-based Charm Industrial, whose technology doesn’t involve energy generation, began its sequestration efforts in the Midwest and plans to expand into Louisiana.

The American South has less stringent logging and environmental regulations, which has led biomass energy projects to flock to the area: In 2024, about 2.3% of the South’s energy came from woody biomass — up from 2% in 2010, according to the U.S. Energy Information Administration. Meanwhile, that number on the West Coast was only 1.2%, continuing on its slow decline.

And, unlike in the West, companies aiming to create wood pellets to ship abroad have proliferated in the South. In 2024, the U.S. produced more than 10.7 million tons of biomass pellets; 82% of which was exported. That’s up from virtually zero in 2000. The vast majority of the biomass pellets produced last year — 84% — was from the South.

Watchdogs warn that this lack of guardrails has allowed the biomass industry to harm the South’s forests, pollute poor communities living near biomass facilities and fall short of its climate claims.

Over the last five years, Drax — a company that harvests and exports wood pellets and was working with Golden State Natural Resources — has had to pay Louisiana and Mississippi a combined $5 million for violating air pollution laws. Residents living next to biomass plants, like Drax’s, say the operations have worsened asthma and routinely leave a film of dust on their cars.

Advertisement

But operating a traditional biomass facility or shipping wood pellets to Europe wasn’t Arbor’s founding goal — albeit powering data centers in the American South wasn’t exactly either.

Hartwig, who grew up in the Golden State, hopes Arbor’s technology can someday return to California to help finance the solution for the wildfire crisis he spent so many years facing head-on.

“We’ve got an interest in Arkansas, in Texas, all the way up to Minnesota,” Hartwig said. “Eventually, we’d like to come back to California.”

Advertisement

Science

What’s in a Name? For These Snails, Legal Protection

Published

on

What’s in a Name? For These Snails, Legal Protection

The sun had barely risen over the Pacific Ocean when a small motorboat carrying a team of Indigenous artisans and Mexican biologists dropped anchor in a rocky cove near Bahías de Huatulco.

Mauro Habacuc Avendaño Luis, one of the craftsmen, was the first to wade to shore. With an agility belying his age, he struck out over the boulders exposed by low tide. Crouching on a slippery ledge pounded by surf, he reached inside a crevice between two rocks. There, lodged among the urchins, was a snail with a knobby gray shell the size of a walnut. The sight might not dazzle tourists who travel here to see humpback whales, but for Mr. Avendaño, 85, these drab little mollusks represent a way of life.

Marine snails in the genus Plicopurpura are sacred to the Mixtec people of Pinotepa de Don Luis, a small town in southwestern Oaxaca. Men like Mr. Avendaño have been sustainably “milking” them for radiant purple dye for at least 1,500 years. The color suffuses Mixtec textiles and spiritual beliefs. Called tixinda, it symbolizes fertility and death, as well as mythic ties between lunar cycles, women and the sea.

The future of these traditions — and the fate of the snails — are uncertain. The mollusks are subject to intense poaching pressure despite federal protections intended to protect them. Fishermen break them (and the other mollusks they eat) open and sell the meat to local restaurants. Tourists who comb the beaches pluck snails off the rocks and toss them aside.

A severe earthquake in 2020 thrust formerly submerged parts of their habitat above sea level, fatally tossing other mollusks in the snail’s food web to the air, and making once inaccessible places more available to poachers.

Advertisement

Decades ago, dense clusters of snails the size of doorknobs were easy to find, according to Mr. Avendaño. “Full of snails,” he said, sweeping a calloused, violet-stained hand across the coves. Now, most of the snails he finds are small, just over an inch, and yield only a few milliliters of dye.

Continue Reading

Science

Video: This Parrot Has No Beak, But Is at the Top of the Pecking Order

Published

on

Video: This Parrot Has No Beak, But Is at the Top of the Pecking Order

new video loaded: This Parrot Has No Beak, But Is at the Top of the Pecking Order

Bruce, a disabled kea parrot, is missing his top beak. The bird uses tools to keep himself healthy and developed a jousting technique that has made him the alpha male of his group.

By Meg Felling and Carl Zimmer

April 20, 2026

Continue Reading

Science

Contributor: Focus on the real causes of the shortage in hormone treatments

Published

on

Contributor: Focus on the real causes of the shortage in hormone treatments

For months now, menopausal women across the U.S. have been unable to fill prescriptions for the estradiol patch, a long-established and safe hormone treatment. The news media has whipped up a frenzy over this scarcity, warning of a long-lasting nationwide shortage. The problem is real — but the explanations in the media coverage miss the mark. Real solutions depend on an accurate understanding of the causes.

Reporters, pharmaceutical companies and even some doctors have blamed women for causing the shortage, saying they were inspired by a “menopause moment” that has driven unprecedented demand. Such framing does a dangerous disservice to essential health advocacy.

In this narrative, there has been unprecedented demand, and it is explained in part by the Food and Drug Administration’s recent removal of the “black-box warning” from estradiol patches’ packaging. That inaccurate (and, quite frankly, terrifying) label had been required since a 2002 announcement overstated the link between certain menopause hormone treatments and breast cancer. Right-sizing and rewording the warning was long overdue. But the trouble with this narrative is that even after the black-box warning was removed, there has not been unprecedented demand.

Around 40% of menopausal women were prescribed hormone treatments in some form before the 2002 announcement. Use plummeted in its aftermath, dipping to less than 5% in 2020 and just 1.8% in 2024. According to the most recent data, the number has now settled back at the 5% mark. Unprecedented? Hardly. Modest at best.

Nor is estradiol a new or complex drug; the patch formulation has existed for decades, and generic versions are widely manufactured. There is no exotic ingredient, no rare supply chain dependency, no fluke that explains why women are suddenly being told their pharmacy is out of stock month after month.

Advertisement

The story is far more an indictment of the broken insurance industry: market concentration, perverse incentives and the consequences of allowing insurance companies to own the pharmacy benefit managers that effectively control drug access for the majority of users. Three companies — CVS Caremark, Express Scripts and OptumRx — manage 79% of all prescription drug claims in the United States. Those companies are wholly owned subsidiaries of three insurance behemoths: CVS Health, Cigna and UnitedHealth Group, respectively. This means that the same corporation that sells you your insurance plan also decides which drugs get covered, at what price, and whether your pharmacy can stock them. This is called vertical integration. In another era, we might have called it a cartel. The resulting problems are not unique to hormone treatments; they have affected widely used medications including blood thinners, inhalers and antibiotics. When a low-cost generic such as estradiol — a medication with no blockbuster profit margins and no patent protection — runs into friction in this system, the friction is not random. It is structural. Every decision in that chain is filtered through the same corporate profit motive. And when the drug in question is an off-patent estradiol patch that has negligible profit margins because of generic competition but requires logistical investment to keep consistently in stock? The math on “how much does this company care about ensuring access” is not complicated.

Unfortunately, there is little financial incentive to ensure smooth, consistent access. There is, however, significant financial incentive to steer patients toward branded alternatives, or simply to let supply tighten — because the companies aren’t losing much profit if sales of that product dwindle. This is not a conspiracy theory: The Federal Trade Commission noted this dynamic in a report that documented how pharmacy benefit managers’ practices inflate costs, reduce competition and harm patient access, particularly for independent pharmacies and for generic drugs.

Any claim that the estradiol patch shortage is meaningfully caused by more women now demanding hormone treatments is a distraction. It is also misogyny, pure and simple, to imply that the solution to the shortage is for women’s health advocates to dial it down and for women to temper their expectations. The scarcity of estradiol patches is the outcome of a broken system refusing to provide adequate supply.

Meanwhile, there are a few strategies to cope.

  • Ask your prescriber about alternatives. Estradiol is available in multiple formulations, including gel, spray, cream, oral tablet, vaginal ring and weekly transdermal patch, which is a different product from the twice-weekly patch and may be more consistently available depending on manufacturer and region.
  • Consider an online pharmacy. Many are doing a good job locating and filling these prescriptions from outside the pharmacy benefit manager system.
  • Call ahead. Patch shortages are inconsistent across regions and distributors. A call to pharmacies in your area, or a broader geographic radius if you’re able, can locate stock that your regular pharmacy doesn’t have.
  • Consider a compounding pharmacy. These sources can sometimes meet needs when commercially manufactured products are inaccessible. The hormones used are the same FDA-regulated bulk ingredients.

Beyond those Band-Aid solutions, more Americans need to fight for systemic change. The FTC report exists because Congress asked for it and committed to legislation that will address at least some of the problems. The FDA took action to change the labeling on estrogen in the face of citizen and medical experts’ pressure; it should do more now to demand transparency from patch manufacturers.

Most importantly, it is on all of us to call out the cracks in the current system. Instead of repeating “there’s a patch shortage” or a “surge in demand,” say that a shockingly small minority of menopausal women still even get hormonal treatments prescribed at all, and three drug companies control the vast majority of claims in this country. Those are the real problems that need real solutions.

Advertisement

Jennifer Weiss-Wolf, the executive director of the Birnbaum Women’s Leadership Center at New York University School of Law, is the author of the forthcoming book When in Menopause: A User’s Manual & Citizen’s Guide. Suzanne Gilberg, an obstetrician and gynecologist in Los Angeles, is the author of “Menopause Bootcamp.”

Continue Reading
Advertisement

Trending